Unknown

Dataset Information

0

Impact on glycated haemoglobin of a biological response-based measure of medication adherence.


ABSTRACT:

Aims

The aim of this study was to examine the relationship between a specific glycated haemoglobin (HbA1c) measurement and a pharmaceutical dispensings-based measure of adherence calculated over the 90 days before each HbA1c measure among patients who have newly initiated metformin therapy.

Methods

We identified 3109 people with type 2 diabetes who initiated metformin as their first-ever antihyperglycaemic drug, analysing all 9918 HbA1c measurements that were taken over the next 2 years. We used an adaptation of the 'proportion of days covered' method for assessing medication adherence that corresponded to an ?90-day interval preceding an HbA1c measurement, terming the adaptation the 'biological response-based proportion of days covered' (BRB-PDC). To account for multiple observations per patient, we analysed the association between HbA1c and BRB-PDC within the generalized estimating equation framework. Analyses were stratified by HbA1c level before metformin initiation using a threshold of 8% (64 mmol/mol).

Results

After multivariable adjustment using 0% adherence as the reference category, BRB-PDC in the range 50-79% was associated with HbA1c values lower by -0.113 [95% confidence interval (CI) -0.202, -0.025] among patients with pre-metformin HbA1c <8%, and by -0.247 (95% CI -0.390, -0.104) among those with HbA1c ?8% at metformin initiation. Full adherence (?80%) was associated with HbA1c values lower by -0.175% (95% CI -0.257, -0.093) and by -0.453% (95% CI -0.586, -0.320).

Conclusions

Using this novel short-interval approach that more closely associates adherence with the expected biological response, the association between better adherence and HbA1c levels was considerably stronger than has been previously reported; however, the strength of the impact was dependent upon the HbA1c level before initiating metformin.

SUBMITTER: Nichols GA 

PROVIDER: S-EPMC5033018 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact on glycated haemoglobin of a biological response-based measure of medication adherence.

Nichols G A GA   Rosales A G AG   Kimes T M TM   Tunceli K K   Kurtyka K K   Mavros P P   Steiner J F JF  

Diabetes, obesity & metabolism 20150520 9


<h4>Aims</h4>The aim of this study was to examine the relationship between a specific glycated haemoglobin (HbA1c) measurement and a pharmaceutical dispensings-based measure of adherence calculated over the 90 days before each HbA1c measure among patients who have newly initiated metformin therapy.<h4>Methods</h4>We identified 3109 people with type 2 diabetes who initiated metformin as their first-ever antihyperglycaemic drug, analysing all 9918 HbA1c measurements that were taken over the next 2  ...[more]

Similar Datasets

| S-EPMC8659020 | biostudies-literature
| S-EPMC7363551 | biostudies-literature
| S-EPMC5704047 | biostudies-literature
| S-EPMC7582150 | biostudies-literature
| S-EPMC2754552 | biostudies-literature
| S-EPMC6277258 | biostudies-literature
| S-EPMC5888154 | biostudies-literature
| S-EPMC4518849 | biostudies-literature
| S-EPMC5780689 | biostudies-other
| S-EPMC5490435 | biostudies-other